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The possible human carcinogen 1,4-dioxane is an emerging environmental contaminant. Although it has been recognized that 1,4-dioxane is recalcitrant to biodegradation, recent studies have isolated bacterial strains capable of utilizing it as the sole carbon and energy source ([@B1]). These findings have suggested that the biological removal of 1,4-dioxane from contaminated environments and wastewater might be possible. However, molecular and enzymatic studies on the mechanism of 1,4-dioxane biodegradation have rarely been performed ([@B2], [@B3]), and even the genome information available is still limited to *Pseudonocardia dioxanivorans* CB1190 and *Mycobacterium dioxanotrophicus* PH-06.

Here, we report the draft genome sequence of *Pseudonocardia* sp. strain N23, a novel strain capable of degrading 1,4-dioxane (N. Yamamoto, Y. Saito, D. Inoue, K. Sei, and M. Ike, unpublished data). Strain N23 has a very high 1,4-dioxane degradation ability and can constitutively express 1,4-dioxane degradation enzymes, unlike the two aforementioned strains.

The genomic DNA of strain N23 was fragmented and prepared into a sequence library using the TruSeq Nano DNA LT library preparation kit (Illumina, San Diego, CA, USA). This library was sequenced by 101-bp paired-end sequencing using the Illumina HiSeq 2500 system, which produced 22,520,910 reads with a yield of 2,275 Mb. From the sequenced reads, the adapter sequences and low-quality value regions were trimmed using the Cutadapt program version 1.1 (<https://cutadapt.readthedocs.io/en/stable/>) ([@B4]) and the Trimmomatic program version 0.32 (<http://www.usadellab.org/cms/?page=trimmomatic>), respectively. The trimmed reads were assembled onto the draft genome sequence using the Velvet program version 1.2.08 (<http://www.ebi.ac.uk/~zerbino/velvet/>). The draft genome sequence of strain N23 contains 173 contigs, accounting for a total of 6,542,330 bp (72.5% G+C content), with an *N*~50~ of 183,452 bp and a maximum contig size of 624,394 bp. A total of 6,230 coding sequences (CDSs), 46 tRNA genes, and 3 rRNA genes were predicted within the genome by the Rapid Annotation using Subsystems Technology pipeline.

Tetrahydrofuran monooxygenase genes, which were closely related to those of 1,4-dioxane-degrading *Pseudonocardia* spp., were found in the strain N23 genome. This indicates that these genes are associated with the initial oxidation of 1,4-dioxane. Glycolate dehydrogenase genes involved in the oxidation of glycolate to glyoxylate, an important intermediate in the proposed 1,4-dioxane degradation pathway ([@B2]), were also found. These genes may be present possibly for 1,4-dioxane metabolism. The absence of genes associated with toxin production and pathogenicity in the genome of strain N23 may suggest that it is safe for use in environmental applications.
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The draft genome sequence and annotation have been deposited in the DDBJ/EMBL/GenBank database under the accession no. [BEGX01000001](http://www.ncbi.nlm.nih.gov/nuccore/BEGX01000001) to [BEGX01000173](http://www.ncbi.nlm.nih.gov/nuccore/BEGX01000173).
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